Trial Profile
Relative and Absolute Bioavailability Study of ACE910 in Healthy Adult Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Emicizumab (Primary) ; Emicizumab (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chugai Pharmaceutical; Roche
- 01 Jun 2016 New trial record